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Abstract 
Efficient strategies for treating enteritis caused by F4+ enterotoxigenic Escherichia coli (ETEC)/verocytotoxigenic 
Escherichia coli (VTEC)/enteropathogenic E. coli (EPEC) in mucin 4 resistant (MUC4 RR; supposed to be F4ab/ac recep‑
tor–negative [F4ab/acR−]) pigs remain elusive. A low (3.9 × 108 CFU/day) or high (7.8 × 108 CFU/day) dose of Bacillus 
licheniformis and Bacillus subtilis spore mixture (BLS‑mix) was orally administered to MUC4 RR piglets for 1 week before 
F4+ ETEC/VTEC/EPEC challenge. Orally fed BLS‑mix upregulated the expression of TLR4, NOD2, iNOS, IL‑8, and IL‑22 
mRNAs in the small intestine of pigs challenged with E. coli. Expression of chemokine CCL28 and its receptor CCR10 
mRNAs was upregulated in the jejunum of pigs pretreated with high‑dose BLS‑mix. Low‑dose BLS‑mix pretreatment 
induced an increase in the proportion of peripheral blood CD4−CD8− T‑cell subpopulations and high‑dose BLS‑mix 
induced the expansion of CD4−CD8− T cells in the inflamed intestine. Immunostaining revealed that considerable 
IL‑7Rα–expressing cells accumulated at the lamina propria of the inflamed intestines after E. coli challenge, even in 
pigs pretreated with either low‑ or high‑dose BLS‑mix, although Western blot analysis of IL‑7Rα expression in the 
intestinal mucosa did not show any change. Our data indicate that oral administration of the probiotic BLS‑mix 
partially ameliorates E. coli‑induced enteritis through facilitating upregulation of intestinal IL‑22 and IκBα expression, 
and preventing loss of intestinal epithelial barrier integrity via elevating ZO‑1 expression. However, IL‑22 also elicits an 
inflammatory response in inflamed intestines as a result of infection with enteropathogenic bacteria.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Enterotoxigenic Escherichia coli bearing F4 fimbriae 
(F4+ ETEC) is the most prevalent ETEC strain in causing 
postweaning diarrhea in pigs [1]. The fimbriae-mediated 
recognition of specific receptors on host enterocytes is 
the prerequisite for infection. Breeding programs with 
F4 receptor–negative pigs is preferable for prevention of 
F4+ ETEC infection, and a polymorphism in the mucin 4 
(MUC4) gene has been developed to allow genotyping for 
determining F4ab/ac ETEC resistance/susceptibility [2, 
3]. According to this DNA marker-based test, pigs were 
genotyped as resistant (RR), susceptible heterozygote 
(SR) and susceptible homozygote (SS). However, MUC4 
RR pigs are now identified not absolutely F4ab/ac recep-
tor–negative (F4ab/acR−) pigs, since there are more than 
30% showing positive adhesion with F4ab/ac ETEC and 
more receptors for F4 fimbriae have been discovered [3–
5]. We recently found that an F4+ enterotoxigenic E. coli 
(ETEC)/verocytotoxigenic E. coli (VTEC)/enteropatho-
genic E. coli (EPEC) hybrid can cause enteritis and/or 
fever in MUC4 RR pigs. This is possibly due to the abil-
ity of this strain to adhere to the intestinal mucosa, and 
subsequently secrete toxins (e.g. heat-liable, heat-stable 
enterotoxins, Shiga-like toxin Stx2e) and release LPS 
[1, 6].
The probiotics Bacillus licheniformis and Bacillus sub-
tilis are widely used in both humans and animals with a 
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broad spectrum of inhibitory activity against pathogenic 
bacteria [7, 8]. Our recent study showed that excessive 
generation of CD4+ interleukin (IL)-10–positive T cells 
following consumption of a B. licheniformis and B. sub-
tilis mixture (BLS-mix) during episodes of intestinal 
inflammation caused by F4+ ETEC/VTEC/EPEC can 
inhibit clearance of the pathogen in newly weaned MUC4 
RR pigs [6]. Effective defense against F4+ ETEC/VTEC/
EPEC achieved through coordination of complex sign-
aling networks linking the innate and adaptive immune 
systems thus remains elusive.
IL-22 is essential for epithelial defense against extra-
cellular bacteria and critical for mediating mucosal host 
defenses against attaching and effacing bacteria in the 
gastrointestinal tract [9]. The central roles of IL-22 in 
the gut include maintaining normal barrier homeostasis, 
inducing the secretion of antibacterial proteins, and trig-
gering the expression of chemokines for controlling the 
spread of invading pathogens [10]. However, IL-22 has 
both protective and pathologic roles, and the effect of 
BLS-mix on IL-22 secretion and its role in pigs infected 
with E. coli is poorly understood.
The induction of IL-10–producing Foxp3− T cells by 
BLS-mix cannot account for the protection of newly 
weaned MUC4 RR pigs from F4+ ETEC/VTEC/EPEC 
infection [6]. CD4+CD25+CD127low cells were used as an 
alternative marker for regulatory T (Treg) cells, in addi-
tion to the conventional CD4+CD25+Foxp3+ popula-
tion [11]. IL-7 receptor α-chain (IL-7Rα, also known as 
CD127) contributes to the development of IL-22–pro-
ducing cells and Treg cells, IL-7/IL-7R–dependent signal-
ing plays a crucial role in regulating the immune response 
in the intestinal mucosa [12, 13]. In swine, CD127 has 
been detected in the intestine, lymphoid tissues, and var-
ious nonlymphoid tissues [14].
Chemokines can attract specific populations of 
immune cells to sites of infection or inflammation [15]. 
Specifically, in humans and mice, the CC chemokine 
receptor CCR9, expressed by IgA antibody-secreting cells 
(ASCs) and T cells, responds to its ligand, CCL25, which 
is selectively expressed in the small intestine and thymus. 
In contrast, chemokine CCL28, a ligand for CCR10 that 
is expressed primarily by IgA ASCs and some T lympho-
cytes, is expressed in mucosa of intestine and elsewhere 
[16]. In pigs, CCL25 recruits T cells and IgA ASCs that 
express CCR9 in the gut-associated lymphoid tissues 
and small intestine, whereas CCL28 can be detected in 
both intestinal and other mucosal tissues [17]. It remains 
to be elucidated that the effect of BLS-mix on these two 
chemokines with their respective receptors in pigs.
Probiotic bacteria increase tight-junction function to 
modulate the mucosal permeability, but the pathways 
involved vary depending on the bacterial strain [18, 
19]. Lactobacillus rhamnosus or Bifidobacterium lactis 
increased the phosphorylation of tight junction proteins 
zonula occludens-1 (ZO-1) and occludin [20]. Activa-
tion of Toll-like receptor 4 (TLR4), nucleotide-binding 
oligomerization domain 1 (NOD1) and NOD2 by com-
mensal microbiota leads to the degradation of IκBα (the 
inhibitor of NF-κB), the activation of the transcription 
factor NF-κB, and release of pro-inflammatory cytokines 
[21]. Protein kinase C (PKC) has been implicated in regu-
lation of tight junctions in response to luminal bacteria 
[22].
In the present study, we hypothesized that IL-22 pro-
duction, T-cell responses, IL-7Rα and tight junction pro-
tein in the intestinal mucosa would be involved in the 
mechanism by which probiotic BLS-mix alleviates the 
progression of inflammation caused by pathogenic bacte-
ria in newly weaned pigs.
Materials and methods
Ethics statement
This study was carried out in strict accordance with the 
Guidelines for Laboratory Animal Use and Care from 
the Chinese Center for Disease Control and Prevention 
and in accordance with the Rules for Medical Laboratory 
Animals from the Chinese Ministry of Health, under the 
protocol (CAU-AEC-2013-073) approved by the Animal 
Ethics Committee of the China Agricultural University, 
as described previously [6]. All animals were euthanized 
under sodium pentobarbital anesthesia, and every effort 
was made to minimize suffering.
Animals
A total of 32 MUC4 RR crossbred (Landrace  ×  Large 
White) piglets of mixed gender, selected from 8 dif-
ferent litters, weaned at 21  days of age, and weighing 
6.80 ± 0.44 kg were obtained from the Beijing Hog Rais-
ing and Breeding Center and used in this study. The DNA 
marker-based test that detection of the polymorphism in 
gene MUC4 was used to discriminate resistant (RR) or 
susceptible (SS, SR) pigs, as described previously [6].
Bacterial strains
An equal mixture of spray-dried spore-forming B. licheni-
formis (DSM 5749) and B. subtilis (DSM 5750) was kindly 
supplied by Chr. Hansen A/S (Hørsholm, Denmark) and 
used in this study. The probiotic mixture at a concen-
tration of 3.2 ×  109 viable spores/g was resuspended in 
sterile physiological saline. A low-(3.9 × 107 CFU/mL) or 
high-dose (7.8 × 107 CFU/mL) solution of the probiotic 
mixture concentrated in 10  mL of sterile physiological 
saline was prepared, respectively.
The uncommon E. coli strain with serotype/virotype 
O149:F4ac:LT:STb:Stx2e:eae (named as F4+ ETEC/
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VTEC/EPEC) was obtained from the China Veterinary 
Culture Collection Center and was grown in Luria–
Bertani medium (Oxoid, Basingstoke, UK). Prior to 
challenge, an inoculum of F4+ ETEC/VTEC/EPEC con-
taining 1.0 × 109 CFU/mL resuspended in 10 mL of ster-
ile physiological saline was prepared.
Experimental design
On the day of weaning (day 0), pigs were assigned to 4 
groups (n = 8 per group) according to weight and ances-
try [6]: control (CONT) group (oral administration of 
sterile physiological saline); ETEC (oral administration of 
sterile physiological saline and F4+ ETEC/VTEC/EPEC); 
LDBE (oral administration of low-dose probiotic mixture 
[3.9 ×  108  CFU/day] and F4+ ETEC/VTEC/EPEC); and 
HDBE (oral administration of high-dose probiotic mix-
ture [7.8 × 108 CFU/day] and F4+ ETEC/VTEC/EPEC). 
All animals were maintained by intragastric administra-
tion without sedation or gastric acid neutralization.
At 9:00 a.m. on days 1–7, pigs in CONT and ETEC 
groups were administered with 10  mL of sterile physi-
ological saline orally, while pigs in LDBE and HDBE 
groups were pretreated with an equal volume of low-dose 
(3.9 × 108 CFU/day, once daily) or high-dose (7.8 × 108 
CFU/day, once daily) BLS-mix solution, respectively. At 
9:00 a.m. on day 8, ETEC, LDBE and HDBE pigs were 
challenged with F4+ ETEC/VTEC/EPEC (1.0  ×  1010 
CFU) resuspended in 10 mL of sterile physiological saline 
orally, whereas CONT pigs received 10  mL of sterile 
physiological saline only. On day 15 (1  week after F4+ 
ETEC/VTEC/EPEC challenge), pigs in four groups were 
sacrificed.
Quantitative PCR amplification of faecal Escherichia 16S 
rRNA gene
To check bacteria shedding, fresh faecal samples 
were collected from all pigs on days 1, 4, 7, 9 and 12. 
Genomic DNA was extracted from 200  mg of faeces 
using a QIAamp DNA Stool Mini Kit (Qiagen, Hilden, 
Germany) according to the manufacturer’s instruc-
tions. Quantitative PCR was performed in ABI 7500 
(Applied Biosystems, Foster City, CA, USA). Each reac-
tion mixture (20  μL) contained 1  μL of DNA template, 
0.5  μM each primer, and 10  µL of GoTaq qPCR Master 
Mix (Promega, Madison, WI, USA). The sequences of 
primers for Escherichia used were as follows: 5′-GAGT 
AAAGTTAATACCTTTGCTCATTG-3′ and 5′-GAGAC 
TCAAGCTKRCCAGTATCAG-3′ [23]. Bacterial DNA 
standards consisted of serial tenfold dilutions (rang-
ing from 100 to 1010 gene copies/μL) of known amounts 
of purified PCR product obtained from faecal genomic 
DNA by using specific primers for Escherichia 16S rRNA 
as above. R2 values for the standard curves were  >0.99 
and the estimated amplification efficiency was 95–105%. 
Samples, standards and non-template controls in tripli-
cate were included in each run.
Flow cytometry
At 0 h (prior to E. coli challenge) and 24, 144 h after chal-
lenge, 3 mL of peripheral blood from the jugular vein of 
each pig was collected using Venoject glass tubes (Ter-
umo Europe NV, Leuven, Belgium) containing EDTA. 
Peripheral blood lymphocytes were isolated by Ficoll 
gradient centrifugation using Lymphocyte Separation 
Solution (TBD Science Inc., Tianjin, China), according 
to the manufacturer’s instructions. In addition, intesti-
nal mucosal lymphocytes [intraepithelial lymphocytes 
(IELs), lamina propria lymphocytes (LPLs), and Peyer’s 
patch lymphocytes (PPLs)] from the jejunal and ileal tis-
sue samples of 10-cm in length were isolated as described 
previously [24].
Briefly, to isolate IELs and LPLs, the opened Peyer’s 
patches-free tissues were cut into 3-cm pieces. The 
intestinal pieces were incubated in Hank’s balanced salt 
solution (HBSS; 10  mM HEPES, 50  U/mL penicillin, 
and 50  μg/mL streptomycin) containing 3  mM EDTA 
and 10 mM HEPES and lacking Ca2+ and Mg2+ (HBSS-
EDTA) for 45 min at 37  °C in a shaking incubator, then 
the solution passed through a sterile 200-μm-pore metal 
sieve and collected for IELs isolation, the above steps 
were repeated twice. The remaining tissues were thor-
oughly washed with RPMI 1640 medium (Gibco, Grand 
Island, NY, USA), followed by digestion with RPMI-colla-
genase (RPMI 1640 containing 100 U/mL collagenase VII 
[Sigma-Aldrich, Saint Louis, MO, USA]) for 45  min at 
37 °C in a shaking incubator. After digestion for 3 times, 
the cell suspension was sedimented at 600 × g for 10 min 
at 4  °C and the resuspended pellet was further purified 
from the interface between 44 and 66% Percoll gradient 
(GE Healthcare, Piscataway, NJ, USA). The PPLs were 
isolated after digestion of the tissues with HBSS-EDTA 
for 20 min at 37 °C with shaking. The cells were released 
through gentle mincing and pelleted by centrifugation 
after passage through a sterile 200-μm metal sieve. Cells 
were purified and collected from the interface between 
40 and 70% Percoll layers.
Cells were counted under a microscope, and viabil-
ity was tested by trypan blue exclusion. In each reac-
tion, 1 × 106 cells were used for staining and more than 
2 ×  104 gated events per condition were acquired. Dif-
ferent proportions of these lymphocytes were assessed 
using CD3/CD4/CD8 triple-color flow cytometry. The 
following monoclonal antibodies were used: mouse 
anti-pig CD3ε (clone BB23-8E6-8C8, fluorescein iso-
thiocyanate–conjugated, 559582; BD Biosciences, San 
Jose, CA, USA), mouse anti-pig CD4α (clone 74-12-4, 
Page 4 of 15Yang et al. Vet Res  (2016) 47:71 
phycoerythrin-conjugated, 561473; BD Biosciences), 
and mouse anti-pig CD8α (clone 76-2-11, conjugated to 
spectral red, GWB-AAEC7C; Gen Way Biotech Inc., San 
Diego, CA, USA). Data collection was performed using a 
FACScalibur™ flow cytometer (BD Biosciences). For data 
analysis, FlowJo software V7.6 (Tree Star) was used.
Quantitative real‑time PCR
Total RNA was extracted from frozen jejunal and ileal 
tissue samples using Trizol reagent (Invitrogen, Carls-
bad, CA, USA) as previously described [25]. The jejunum 
was sampled without Peyer’s patches involvement. The 
concentration and purity of the RNA was detected using 
NanoDrop® ND-2000C spectrophotometer (Thermo 
Fisher Scientific, Wilmington, DE, USA) and the integ-
rity of RNA was confirmed by agarose gel electropho-
resis with ethidium bromide staining and visualization 
under UV light. Complementary DNA was synthesized 
from 1 μg of total RNA using the GoScript reverse tran-
scription system (Promega). Transcripts were quantified 
using SYBR® Premix DimerEraser™ (TakaRa Biotechnol-
ogy Inc., Dalian, China) on an ABI 7500 Real-time PCR 
System (Applied Biosystems). To guarantee no genomic 
DNA contamination, 1  μg of not-reverse-transcribed 
RNA of each RNA sample was included. The sequences 
of the primers used are listed in Additional file 1.
Relative mRNA expression was determined by normal-
ization to the geometric mean of the CT values of three 
selected reference genes, including hypoxanthine phos-
phoribosyl-transferase (HPRT), glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH), and β-actin, and the 
results are presented as fold change, as determined using 
the 2−ΔΔCT method [6].
Immunohistochemistry
Proximal, mid, and distal segments (approximately 
10 × 15 × 3 mm) of the ileum were fixed in 4% paraform-
aldehyde, and the samples were then embedded in paraf-
fin and sectioned at 3-μm. The sections were rehydrated, 
and after antigen retrieval in citrate buffer (10  mM, pH 
6), the peroxidase activity of the sections was quenched 
with 3% H2O2 in methanol for 30  min. After washing 
with phosphate-buffered saline (PBS), the sections were 
blocked with 5% bovine serum albumin in PBS for 30 min 
and incubated at 4  °C in a humidified chamber for 14 h 
with polyclonal rabbit anti-human IL-7Rα antibody 
(ab115249; 1:200 dilution) (Abcam). The sections were 
labeled with a 1:200 dilution of biotinylated goat anti-
rabbit secondary antibody for 2  h at room temperature 
and then washed three times with PBS. Next, the sec-
tions were incubated with StreptAvidin–Biotin Complex 
(Vectastain Elite ABC Kit; Vector Laboratories, Burl-
ingame, CA, USA) for 1 h at 37 °C. The reaction product 
was visualized with 3,3′-diaminobenzidine (Zhongshan 
Golden Bridge Biotechnology Co., Beijing, China). Nega-
tive controls were performed using the same procedure 
with the exception of replacing the primary antibody 
with PBS and irrelevant rabbit serum in each batch. 
Images were captured using an Olympus BX41 micro-
scope (Olympus, Tokyo, Japan) equipped with a Canon 
EOS 550D camera head (Canon, Tokyo, Japan).
Western blotting
Intestinal tissue samples were collected immediately 
after animals were euthanized. Each jejunal tissue sam-
ple (except for ileal tissues used for IL-7Rα detection) 
weighing 0.1 g was lysed for 5 min in 1 mL of cold Radio-
Immunoprecipitation Assay (RIPA; 50  mM Tris–HCl, 
pH 8.0, 150  mM sodium chloride, 1.0% Nonidet P-40, 
0.5% sodium deoxycholate, 0.1% sodium dodecyl sul-
fate) buffer supplemented with 5  μL of protease inhibi-
tor cocktail, and 1  mM phenylmethanesulfonyl fluoride 
(Sigma-Aldrich). The tissue lysates were centrifuged at 
12 000 × g for 15 min at 4 °C to remove insoluble mate-
rial, and the total protein content of the resulting super-
natants was quantified using the BCA method (Thermo 
Fisher Scientific, Waltham, MA, USA). An equal amount 
of 20 μg of protein extracts from each sample was used 
for Western blot analyses. The following primary anti-
bodies were used: monoclonal rabbit anti-human IκBα 
(ab32518, 1:5000 dilution), polyclonal rabbit anti-human 
IL-7Rα (ab115249, 1:5000 dilution), monoclonal rabbit 
anti-human PKCα (ab32376, 1:5000 dilution), polyclonal 
rabbit anti-pig ZO-1 (ab59720, 1:50 dilution), poly-
clonal rabbit anti-pig occludin (ab31721, 1:250 dilution) 
(Abcam), monoclonal mouse anti-β-actin (60008-1-Ig, 
1:2000 dilution), and monoclonal mouse anti-GAPDH 
(60004-1-Ig, 1:2000 dilution) (Proteintech, Chicago, 
IL, USA). The following secondary antibodies used 
were purchased from Proteintech: horseradish peroxi-
dase–conjugated affinipure goat anti-rabbit IgG (H+L) 
(SA00001-2) and goat anti-mouse IgG (H+L) (SA00001-
1). Immobilon Western chemiluminescent HRP substrate 
(Millipore, Medford, MA, USA) was used for visualiza-
tion of the blots. The bands were visualized using Tanon-
5200 Gel image system (Tanon, Shanghai, China). The 
intensity of bands was quantified by densitometric analy-
sis using Image J software (National Institutes of Health, 
Bethesda, MD, USA). Results are presented as the ratio of 
the intensity of the IκBα, PKCα, ZO-1, or occludin band 
to that of the β-actin band or the ratio of the intensity of 
the IL-7Rα band to that of the GAPDH band.
Statistical analysis
Statistical analysis was performed using the SAS software 
package, version 9.3 (SAS Institute Inc., Cary, NC, USA). 
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Data were analyzed using the software’s PROC MIXED 
procedure, as described previously [6]. The fixed effects 
of treatment, litter, sex, sampling time, intestinal section, 
interactions between treatments, and sampling time or 
intestinal section, as well as random effects associated 
with individual pigs within a treatment were included in 
the statistical model. Differences between least-square 
means were compared using Tukey’s test. Results were 
presented as the mean ±  SEM. A P value of  <0.05 was 
considered indicative of statistical significance.
Results
BLS‑mix consumption reduced the abundance 
of Escherichia in faeces following E. coli challenge
Prior to F4+ ETEC/VTEC/EPEC challenge, the num-
bers of Escherichia was increased in faeces of LDBE pigs 
7  days after BLS-mix administration compared with 
ETEC pigs (P =  0.043; Additional file  2). One day after 
E. coli challenge (day 9), the faeces of ETEC pigs but not 
pigs pretreated with either low- or high-dose BLS-mix 
had increased numbers of Escherichia compared with 
CONT pigs (P = 0.010). This increase was continuously 
observed on day 12 (P < 0.001).
Effect of orally fed BLS‑mix on TLR4‑ and NOD‑mediated 
inflammatory responses in the small intestine
The expression of jejunal TLR4 mRNA was higher in 
pigs pretreated with either low- or high-dose BLS-mix 
compared with CONT pigs (P  =  0.014 and P  =  0.038, 
respectively), and expression of jejunal TLR4 mRNA 
was also higher in LDBE pigs than ETEC pigs (P = 0.034; 
Figure  1A). In addition, higher expression of NOD1 
mRNA was observed in jejunal tissue of LDBE pigs com-
pared with ETEC pigs (P  =  0.027; Figure  1B). NOD2 
mRNA expression in the jejunal tissues of both LDBE 
and HDBE pigs was upregulated compared with CONT 
pigs (P = 0.040 and P = 0.033, respectively; Figure 1C).
Western blot analysis revealed that the expression of 
IκBα was higher in the jejunal tissues of LDBE pigs com-
pared with CONT pigs (P = 0.011; Figure 1D). Compared 
with CONT and ETEC pigs, the expression of jejunal 
iNOS mRNA was upregulated in pigs pretreated with 
either low- or high-dose BLS-mix (Figure  1E). In addi-
tion, the expression of ileal IL-8 mRNA was upregulated 
in both LDBE and HDBE pigs compared with CONT 
pigs (P = 0.025 and P = 0.001, respectively), and it was 
also higher in HDBE pigs than ETEC pigs (P  =  0.008; 
Figure 1F).
Effect of orally fed BLS‑mix on peripheral blood 
lymphocytes
To investigate whether the immunomodulatory effect 
associated with BLS-mix involves modulation of 
systemic lymphocyte subpopulations, we analyzed the 
CD3+ T-cell subpopulations including CD4+CD8−, 
CD4−CD8+, CD4+CD8+, and CD4−CD8− T cells in 
peripheral blood.
Representative dot plots showed the gating strat-
egy for peripheral blood lymphocytes (Figures  2A–C). 
Analysis of different T-cell subpopulations revealed 
that the percentage of CD4+CD8− T cells was lower in 
LDBE pigs than CONT pigs (P  =  0.048) at 24  h after 
F4+ ETEC/VTEC/EPEC challenge (Figure  2D). In con-
trary, the percentage of CD4−CD8+ subpopulation was 
increased in pigs pretreated with either low- or high-
dose BLS-mix compared with ETEC pigs (P  =  0.021 
and P =  0.044, respectively) at 144  h after F4+ ETEC/
VTEC/EPEC challenge (Figure  2E). The percentage 
of CD4+CD8+ T cells was higher in HDBE pigs com-
pared with both CONT and ETEC pigs (P = 0.030 and 
P = 0.018, respectively) at 24 h after F4+ ETEC/VTEC/
EPEC challenge (Figure 2F).
Notably, the percentage of CD4−CD8− T cells 
was higher in LDBE but not HDBE pigs than CONT 
and ETEC pigs 1  week after BLS-mix administra-
tion (P  =  0.035 and P  <  0.001, respectively). However, 
the percentage of CD4−CD8− T cells did not differ at 
24 and 144  h after F4+ ETEC/VTEC/EPEC challenge 
(Figure 2G).
Effect of orally fed BLS‑mix on expression of intestinal IL‑22 
and selected chemokine mRNAs
The peripheral IL-22 levels in serum were under detec-
tion (<5  pg/mL) by ELISA analysis. To explore the role 
of IL-22 in intestinal mucosa immunity, we quantified the 
expression of mRNAs for IL-22 and selected chemokines 
in both jejunal and ileal tissues.
Compared with CONT or ETEC pigs, jejunal IL-22 
mRNA expression was upregulated in both LDBE 
(P  =  0.040 and P  =  0.008, respectively) and HDBE 
(P = 0.008 and P = 0.002, respectively) pigs (Figure 3A). 
However, no upregulation of the expression of IL-23p19 
mRNA in the small intestine was observed after F4+ 
ETEC/VTEC/EPEC challenge, even in pigs pretreated 
with BLS-mix (Figure 3B).
Although no changes in the expression of mRNAs for 
CCL25 and its receptor CCR9 were observed in the small 
intestine after F4+ ETEC/VTEC/EPEC challenge (even 
in pigs pretreated with BLS-mix), compared with CONT 
and ETEC pigs, the expression of jejunal CCL28 mRNA 
was upregulated (P < 0.001) in pigs pretreated with high-
dose (but not low-dose) BLS-mix (Figures  3C–E). In 
parallel, jejunal CCR10 mRNA expression was upregu-
lated in pigs pretreated with high-dose (but not low-
dose) BLS-mix, compared with CONT and ETEC pigs 
(P = 0.023 and P = 0.029, respectively; Figure 3F).
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Presence of IL‑7Rα–expressing cells in the ileal mucosa
Immunostaining showed that IL-7Rα was predominantly 
localized in the surface epithelium and the lamina pro-
pria, as well as Peyer’s patches, with sporadic positive 
staining (Figure 4A). A considerable number of IL-7Rα–
positive cells infiltrated into the lamina propria of the 
inflamed mucosa in ETEC pigs, even in those pretreated 
with either low- or high-dose BLS-mix. However, West-
ern blot analysis revealed no differences in the expression 
of IL-7Rα among the four groups (Figure 4B).
Effect of orally fed BLS‑mix on intestinal lymphocytes
We assessed changes in different proportions of T-cell 
subpopulations among lymphocytes in the intestinal 
compartments, including the Peyer’s patches, the 
intraepithelial layer, and the lamina propria of the jeju-
num and ileum.
An increase in the percentage of CD4+CD8− T cells 
among iLPLs was observed in pigs pretreated with either 
low- or high-dose BLS-mix compared with CONT pigs 
(P = 0.047 and P = 0.004, respectively), and this increase 
in HDBE pigs was also observed compared with ETEC 
pigs (P = 0.003; Figure 5B). However, no changes in the 
percentage of CD4+CD8− T cells among PPLs, jIELs and 
jLPLs were found after F4+ ETEC/VTEC/EPEC chal-
lenge, even in pigs pretreated with BLS-mix.
The percentage of CD4−CD8+ T cells among jPPLs was 
lower in pigs pretreated with either low- or high-dose 
Figure 1 Effect of orally fed BLS-mix on TLR4- and NOD-mediated inflammatory responses in the small intestine. The relative expres‑
sion of mRNAs for genes encoding A TLR4, B NOD1, C NOD2, E iNOS, and F IL‑8 in both jejunal and ileal tissues collected from the indicated pigs 
1 week after F4+ ETEC/VTEC/EPEC challenge was analyzed using quantitative real‑time PCR. D Western blot analysis of IκBα expression in jejunal tis‑
sues collected from the indicated pigs 1 week after F4+ ETEC/VTEC/EPEC challenge. Representative IκBα expression in jejunal tissues collected from 
2 pigs of each group is shown (left panel). Results are presented as the ratio of IκBα band intensity to the intensity of the β‑actin band (right panel). 
Data are expressed in arbitrary units (A.U.) as the mean ± SEM for each tissue (n = 8 per group). *P < 0.05; **P < 0.01.
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BLS-mix than ETEC pigs (P  <  0.001 and P  =  0.013, 
respectively), and this decrease in LDBE pigs was 
observed compared with CONT pigs (P  =  0.017; 
Figure  5C). Similarly, CD4−CD8+ T cells among jIELs 
and jLPLs were decreased in pigs pretreated with either 
a low or high dose of BLS-mix compared with both 
CONT and ETEC pigs. Similar to subpopulation data, 
significant decreases in the percentage of CD4+CD8+ 
Figure 2 Effect of orally fed BLS-mix on peripheral blood lymphocytes. Peripheral blood samples were collected from the indicated pigs 
at 0, 24, and 144 h after F4+ ETEC/VTEC/EPEC challenge. A FSC‑A/SSC‑A dot plot of peripheral blood lymphocytes, cells with no gating. B CD3 dot 
plot, cells were gated on lymphocytes. C CD4/CD8 dot plot, cells were gated on CD3+. Flow cytometry analysis of the percentages of D CD4+CD8−, 
E CD4−CD8+, F CD4+CD8+, G CD4−CD8− cells among CD3+ T cells. Data are presented as the mean ± SEM for each time point (n = 8 per group). 
*P < 0.05; ***P < 0.001.
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T cells among PPLs, jIELs and jLPLs were observed in 
pigs pretreated with either low- or high-dose BLS-mix 
compared with both CONT and ETEC pigs (P  <  0.05; 
Figure 5D).
In the jejunum, pigs pretreated with either low- 
or high-dose BLS-mix had a higher percentage of 
CD4−CD8− T cells in the Peyer’s patches, intraepithe-
lium and lamina propria than did ETEC pigs (P  <  0.01; 
Figure  5E). The increased CD4−CD8− T cells among 
jIELs and jLPLs in pigs pretreated with either a low or 
high dose of BLS-mix were also observed compared with 
CONT pigs (P < 0.001).
Figure 3 Orally fed BLS-mix upregulates the expression of IL-22 and chemokine mRNAs in the small intestine. The expression of mRNAs 
for the A IL‑22, B IL‑23p19, C CCL25, D CCL28, E CCR9, and F CCR10 genes in both jejunal and ileal tissues collected from the indicated pigs 1 week 
after F4+ ETEC/VTEC/EPEC challenge was analyzed using quantitative real‑time PCR. Data are presented as the mean ± SEM for each tissue (n = 8 
per group). *P < 0.05; **P < 0.01; ***P < 0.001.
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Effect of orally fed BLS‑mix on PKC‑α, ZO‑1, and occludin 
expression
Western blot analysis revealed a reduction in the expres-
sion of PKC-α in the jejunum of ETEC pigs compared 
with CONT pigs (Figure  6A). Consistent with our 
hypothesis, compared with CONT pigs, the expression 
of both ZO-1 and occludin was lower in the jejunum of 
ETEC pigs (but not LDBE pigs) following F4+ ETEC/
VTEC/EPEC challenge (P = 0.013 and P = 0.015, respec-
tively; Figures  6B  and C). Furthermore, the expression 
of both ZO-1 and occludin in the jejunum of HDBE pigs 
was lower compared with CONT pigs (P  =  0.009 and 
P = 0.020, respectively).
Discussion
The outcome of F4+ ETEC/VTEC/EPEC infection in 
MUC4 RR pigs includes fever, anorexia, depression, 
weight loss, mild diarrhea, the onset of enteritis in the 
small intestine and excessive systemic inflammatory 
responses [6]. As more receptors for F4+ ETEC have 
been reported [4], our findings suggest that not only the 
MUC4 polymorphism but also one or more of the F4ac 
receptors should be included in the screening assay for 
F4ab/acR− pigs.
The use of select probiotic mixtures may allow for 
tailoring strategies to prevent infectious diseases. Our 
previous findings indicated that excessive generation of 
CD4+IL-10+ T cells induced by oral administration of 
BLS-mix to newly weaned MUC4 RR pigs with enteritis 
caused by an enteric pathogen might prohibit clearance 
of the pathogen [6]. BLS-mix pretreatment reduces the 
faecal Escherichia shedding following F4+ ETEC/VTEC/
EPEC challenge. It appears that only low dose of BLS-
mix ameliorates E. coli-induced enteritis in the jejunum, 
whereas high dose of BLS-mix makes it worse in both the 
jejunum and ileum.
Entero-invasive bacteria can directly and indirectly 
activate NF-κB in IECs, a process that leads to the pro-
duction of inflammatory mediators such as the pro-
inflammatory cytokines IL-1β, IL-6, and TNF-α, the 
chemokine IL-8, the enzyme iNOS, and various adhe-
sion molecules [26]. In addition to the invading bacteria, 
Figure 4 Presence of IL-7Rα–expressing cells in the ileal mucosa. A Representative photomicrographs of immunostaining of IL‑7Rα and neg‑
ative control of irrelevant rabbit serum in ileal tissues collected from the indicated pigs 1 week after F4+ ETEC/VTEC/EPEC challenge. IL‑7Rα–positive 
cells were predominantly localized in the surface epithelium and the lamina propria, as well as Peyer’s patches, with sporadic positive staining. Scale 
bars, 100 μm. B Representative Western blot results for IL‑7Rα in ileal tissues collected from 2 pigs of each group are shown (upper panel). Results 
are presented as the ratio of the IL‑7Rα band intensity to the intensity of the GAPDH band (lower panel). Data are expressed in arbitrary units (A.U.) 
as the mean ± SEM for each tissue (n = 8 per group).
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the probiotic organism B. lactis strain BB12 was also 
shown to activate NF-κB and trigger a pro-inflamma-
tory response in IECs of germ-free rats after bacterial 
colonization [27]. Consistently, we found that BLS-mix 
pretreatment helps to activate NF-κB and induce IL-8 
and iNOS mRNA expression, and that increased 
Figure 5 Effect of orally fed BLS-mix on intestinal lymphocytes. A Representative dot plots showed the gating strategy for gut T‑cell sub‑
populations. Flow cytometry analysis of the percentage of B CD4+CD8−, C CD4−CD8+, D CD4+CD8+, E CD4−CD8− cells among intestinal CD3+ T 
cells. Peyer’s patch lymphocytes (PPLs), intraepithelial lymphocytes (IELs), and lamina propria lymphocytes (LPLs) were collected from jejunal and 
ileal tissues from the indicated pigs 1 week after F4+ ETEC/VTEC/EPEC challenge. Data are presented as the mean ± SEM for each tissue (n = 8 per 
group). *P < 0.05; **P < 0.01; ***P < 0.001.
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expression of IκBα might in turn inhibit NF-κB activity in 
the small intestine of E. coli-infected pigs pretreated with 
low-dose BLS-mix. It has been suggested that activation 
of the alternative pathway of NF-κB can target genes 
involved in the secondary lymphoid organs development 
and adaptive immunity [26, 28].
Moreover, IL-22 induces the activation of NF-κB, lead-
ing in turn to increased accumulation of inflammatory 
mediators [29]. An increased production of IL-22 in the 
serum was found 1 day after Salmonella enterica serovar 
Enteritidis infection in mice [30]. The systemic IL-22 lev-
els were elevated in Crohn’s disease patients (<24 pg/mL) 
in comparison with healthy participants and systemic 
IL-22 should derive from the sites where activated T cells 
were present [31]. In humans, IL-22–producing CD4+ 
T cells in the peripheral blood are predominantly Th22 
cells (approximately 50%), Th1 cells (33%), and Th17 cells 
(15%) [13]. It has been reported that CD4−CD8− T-cell 
populations composed of γδ T and natural killer T (NKT) 
cells as well as innate lymphoid cells also produce IL-22 
[9, 13]. Flow cytometry analyses of peripheral blood 
lymphocytes revealed that increases in the proportion 
of CD4−CD8− T-cell subpopulation are induced by oral 
administration of low-dose BLS-mix, although the level 
of IL-22 in the serum was extremely low. The number and 
cytokine profile of γδ T cells which isolated from the per-
itoneal cavity altered in mice inoculated with pathogens 
including E. coli [32]. In addition to the cell surface–asso-
ciated IL-22 receptor complex, a soluble IL-22–binding 
receptor (IL-22–binding protein [IL-22BP]) has been 
identified, and it has been postulated that an increase 
in the IL-22:IL-22BP ratio in the inflamed colons is 
Figure 6 Effect of orally fed BLS-mix on PKC-α, ZO-1, and occludin expression. Western blot analysis of PKC‑α, zonula occludens‑1 (ZO‑1), 
and occludin expression in jejunal tissues collected from pigs 1 week after F4+ ETEC/VTEC/EPEC challenge. A Representative Western blot results for 
PKC‑α in jejunal tissues collected from 1 pig of each group are shown. B Representative Western blot results for ZO‑1 and occludin in jejunal tissues 
collected from 2 pigs of each group are shown. C Results are presented as the ratio of the intensity of the ZO‑1 or occludin band to the intensity of 
the β‑actin band. Data are expressed in arbitrary units (A.U.) as the mean ± SEM for each tissue (n = 8 per group). *P < 0.05; **P < 0.01.
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the cause of increased systemic IL-22 levels observed 
in inflammatory bowel disease [31]. Hence, the BLS-
mix–induced expansion of CD4−CD8− T cells before 
an enteric pathogen infection may contribute to the 
IL-22 production after activation for prevention of the 
systemic inflammation. The pathologic effects of IL-22 
may depend on the uncontrolled release of inflamma-
tory mediators, resulting in inflammatory symptoms. It 
remains to be determined about the IL-22 secretion abil-
ity of peripheral CD4−CD8− T cells.
At mucosal surface (e.g. the intestinal tract), IL-22 
targets epithelial cells and induces the production of 
antibacterial proteins and selected chemokines [10]. 
Consistent with the upregulation of jejunal IL-22 mRNA 
expression, the expression of jejunal TNF-α, IL-6, and 
T-bet mRNA is also upregulated in pigs pretreated with 
low-dose BLS-mix [6]. However, the IL-23p19 mRNA 
expression in the small intestine was not influenced by 
BLS-mix pretreatment. It is possible that development 
of IL-22–producing cells occurs via an IL-6–dependent 
mechanism and is dependent on the transcription factors 
T-bet and AhR [33]. IL-22 expression is highly increased 
in the intestine after infection with Clostridium diffi-
cile [34]. Although IL-22 is considered to prevent colitis 
development [35], it also promotes pathogen coloniza-
tion by suppressing related commensal bacteria in mice 
[36]. In turn, the gut microbiota and its products are 
required for the development of IL-22–producing cells 
and IL-22 production [37]. Our data suggest that IL-22 
induced by orally fed BLS-mix not only acts on the intes-
tine to maintain the mucosal homeostasis [9], it also 
promotes an inflammatory response in inflamed intes-
tinal mucosal tissues as a result of infection with enter-
opathogenic bacteria. Further research should identify 
the IL-22–expressing cells in pigs and discover the role of 
IL-22 in mediating pathogen colonization and intestinal 
inflammation that caused by enteric pathogens.
The chemokine CCL25 regulate trafficking of T lym-
phocytes to the gut under physiologic and pathophysi-
ologic conditions [38]. Surprisingly, no changes in the 
expression of CCL25 mRNA or mRNA of its receptor, 
CCR9, were observed in the small intestine following F4+ 
ETEC/VTEC/EPEC challenge, even in pigs pretreated 
with either low- or high-dose BLS-mix. Although CCL25 
mRNA expression has been shown to be upregulated in 
the small intestine in the presence of E. coli [39], CCL25 
expression is restricted to the small intestine and thymus 
[16], and CD4+Foxp3+ Treg cells do not require CCR9 
expression to traffic into and function in the inflamed 
colonic lamina propria in mice [40]. Blockade of CCR9 
or CCL25 does not attenuate inflammation during the 
late stages of chronic murine ileitis [41]. Collectively, 
CCL25 in the small intestine is considered to play its role 
in trafficking and homing T cells between bone marrow, 
lymphoid organs and sites of infection or inflammation 
for generation of immune responses [38].
Intriguingly, higher levels of mRNA for chemokine 
CCL28 and its receptor CCR10 were observed in the 
jejunum of F4+ ETEC-infected pigs pretreated with high-
dose BLS-mix. A previous study reported upregulation 
of the expression of CCL28 and CCR10 mRNA in the 
small intestine of pigs orally inoculated with E. coli com-
pared with germ-free pigs [39]. In humans, expression of 
CCL28 is increased in the inflamed colon of patients with 
ulcerative colitis [42]. CCL28 production and recruit-
ment of CCR10+ Treg cells to the inflamed liver tissue 
were reported to be involved in the epithelial inflamma-
tion in humans [43]. Besides, CCL28 might participate 
in mediating the accumulation of CCR10-expressing IgA 
ASCs in the porcine mucosal tissues [44]. Taken together, 
the upregulated expression of CCL28 and CCR10 in the 
intestinal mucosa following consumption of high-dose 
BLS-mix is partly involved in clearance of the pathogen, 
but also is associated with intestinal inflammation during 
E. coli infection.
The survival of mature and naïve T cells as they circu-
late between the blood and secondary lymphoid organs 
requires IL-7/IL-7Rα signaling [12]. However, IL-7 
exacerbates chronic colitis, with expansion of mucosal 
CD4+IL-7Rhigh T cells in mice [45]. An increase in the 
infiltration of IL-7R-positive cells was reported in the 
lamina propria of TCRα−/− mice with chronic colitis 
[46]. The proportion of IL-7R-positive macrophages 
was shown to decrease after treatment with the lysate 
of the probiotic Lactobacillus casei DN-114001 along 
with LPS, compared with cells treated only with LPS 
[47]. In the present study, we found that considerable 
IL-7Rα–expressing cells infiltrate into the lamina pro-
pria of inflamed intestinal tissues after F4+ ETEC/VTEC/
EPEC challenge, even in pigs pretreated with either 
low- or high-dose BLS-mix. IL-17A–producing IL-7Rα+ 
innate lymphoid cells are potent promoters of intestinal 
inflammation in Tbx21−/−Rag2−/− ulcerative colitis mice 
[48]. Of note, in a recent study of Citrobacter rodentium 
infection in mice, IL-7Rα blockade impaired the bacte-
rial clearance, decreased IL-22 mRNA level, enhanced 
the structural disruption and intestinal inflammation in 
colon epithelium, demonstrating that intestinal epithe-
lium-derived IL-7 played a critical role in the protective 
immunity against intestinal pathogens [49]. The crucial 
role of IL-7/IL-7Rα signaling in regulating the intestinal 
inflammation caused by enteric pathogens still needs to 
be defined.
IL-7Rα is required for the development of γδ T cells 
and NKT cells in humans and mice [12]. In the pre-
sent study, not only low-dose BLS-mix consumption 
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induced an increase of CD4−CD8− T cells in the 
jejunum of E. coli-infected pigs, but high-dose 
BLS-mix consumption also enhanced the expan-
sion of CD4−CD8− T cells in the inflamed intestine. 
CD4−CD8− αβ and γδ T cells display both pro-inflam-
matory and regulatory profiles in patients infected with 
Mycobacterium tuberculosis [50]. Resident γδ T cells in 
mesenteric sites of TCR-β−/− mice fuel Th17 responses 
and actively participate in colitis development, sug-
gesting a pathogenic role of γδ T cells in intestinal 
inflammation [51]. In addition, as lymph nodes are spe-
cialized sites for T-cell priming, effector T cells then 
migrate from lymph nodes to the sites of infection and 
inflammation in order to perform their immune func-
tions [15]. The change in the proportion of γδ T cells 
in Peyer’s patches is probably related with the degree 
and diversity of gut colonization in swine [52]. Based 
on these data, we therefore hypothesize that increased 
CD4−CD8− T cells accumulated at the inflamed intes-
tines are implicated in the intestinal inflammation. Fur-
ther, the subpopulations of CD4−CD8− T cells and γδ 
T cells should be identified in pigs and the interaction 
of the bacterial colonization with CD4−CD8− T-cell 
response within the inflamed intestine needs to be 
explored in future investigations.
IL-22–mediated barrier maintenance involves regulat-
ing tight junctions between IECs [13]. Tight junction bar-
rier loss is sufficient to cause inflammatory bowel disease 
[19]. Our results showed that the expression of ZO-1 and 
occludin decreases after F4+ ETEC/VTEC/EPEC infec-
tion. Consistent with our results, E. coli heat-stable toxin 
b induces intestinal epithelial barrier dysfunction via 
altering tight junction proteins [53]. Furthermore,F4+ E. 
coli infection results in decreased expression of ZO-1 and 
occludin in porcine intestinal epithelial J2 cells (IPEC-J2) 
[54]. In accordance with the observed upregulation of 
IL-22 mRNA expression, pretreatment with the probi-
otic BLS-mix also enhanced the expression of PKC-α and 
ZO-1 in jejunal mucosa in the present study. In addition 
to the probiotic BLS-mix, pretreatment with L. rhamno-
sus also result in upregulation of ZO-1 expression [54]. 
The biogenesis of tight junctions is regulated selectively 
by PKC, and it appears that TLR2 enhances ZO-1-asso-
ciated intestinal epithelial barrier integrity via PKC [22]. 
Notably, in the present study, administration of low-dose 
(but not high-dose) BLS-mix promoted expression of the 
tight junction protein ZO-1. Bacillus-derived lipoteichoic 
acid treatment enhanced the expression of tight junc-
tion proteins including ZO-1 and occludin in the IPEC-
J2 cells [55]. However, during processes of inflammation, 
overexpression of inflammatory mediators (e.g. iNOS) 
can cause cell and tissue damage, and hence leads to 
the deceased expression of tight junction proteins [56]. 
Our data indicate that administration of a low dose of 
probiotic BLS-mix may enhance intestinal epithelial 
barrier integrity through upregulation of ZO-1 expres-
sion; however, inflammatory mediators and changes in 
PKC-α activity might also contribute to the relocalization 
of ZO-1 in gut tissues infected with enteropathogenic 
bacteria.
In conclusion, our data indicate that the development 
of intestinal inflammation in MUC4 RR pigs following 
F4+ E. coli challenge is associated with the accumula-
tion of IL-7Rα–expressing cells in the lamina propria of 
inflamed intestines. Orally fed probiotic BLS-mix leads to 
an increase in the expression of intestinal IL-22, IκBα and 
ZO-1, thereby contributing to the amelioration of intesti-
nal inflammation and maintenance of intestinal epithelial 
barrier integrity. However, expansion of CD4−CD8− T 
cells and increased IL-22 expression following con-
sumption of BLS-mix may also elicit an inflammatory 
response involved in intestinal inflammation caused by 
enteropathogenic bacteria. Our data suggest a low dose 
(3.9 × 108 CFU/day) of probiotic BLS-mix may allow for 
protecting the host against enteric pathogens in clinical 
practice.
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